MarketBeat
C4 Therapeutics Maps Cemsidomide Phase II Launch, BCMA Combo Plans at Guggenheim Conference
📈
AI Sentiment
Highly Positive
8/10
C4 Therapeutics Inc. News
Latest updates and market news for CCCC
2 news
Feb 8 - Feb 14, 2026
Page 1
GlobeNewswire
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
📊
AI Sentiment
Positive
6/10
Share this news page